Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H40F3N5O2 |
Molecular Weight | 559.6661 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCO[C@@H]1CC2=C(C=CC(=C2)C(F)(F)F)[C@H]1N3CCN(C[C@@H]3C)C4(C)CCN(CC4)C(=O)C5=C(C)N=CN=C5C
InChI
InChIKey=ZMCJFJZOSKEMOM-DNKZPPIMSA-N
InChI=1S/C30H40F3N5O2/c1-6-40-25-16-22-15-23(30(31,32)33)7-8-24(22)27(25)38-14-13-37(17-19(38)2)29(5)9-11-36(12-10-29)28(39)26-20(3)34-18-35-21(26)4/h7-8,15,18-19,25,27H,6,9-14,16-17H2,1-5H3/t19-,25+,27+/m0/s1
Molecular Formula | C30H40F3N5O2 |
Molecular Weight | 559.6661 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
INCB9471 is a non-competitive, potent and selective CCR5 small-molecule antagonist patented by pharmaceutical company Incyte Corporation for treatment of human immunodeficiency virus infection. INCB9471 potently inhibited macrophage inflammatory protein-1beta-induced monocyte migration and infection of peripheral blood mononuclear cells by a panel of R5-HIV-1 strains. INCB9471 was shown to be safe and highly efficacious in reducing HIV viral load in phase I and II human clinical trials
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00393120
300 mg orally once daily
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:58:51 GMT 2023
by
admin
on
Sat Dec 16 04:58:51 GMT 2023
|
Record UNII |
C5D4W25708
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB12960
Created by
admin on Sat Dec 16 04:58:52 GMT 2023 , Edited by admin on Sat Dec 16 04:58:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL1688243
Created by
admin on Sat Dec 16 04:58:52 GMT 2023 , Edited by admin on Sat Dec 16 04:58:52 GMT 2023
|
PRIMARY | |||
|
49871007
Created by
admin on Sat Dec 16 04:58:52 GMT 2023 , Edited by admin on Sat Dec 16 04:58:52 GMT 2023
|
PRIMARY | |||
|
C5D4W25708
Created by
admin on Sat Dec 16 04:58:52 GMT 2023 , Edited by admin on Sat Dec 16 04:58:52 GMT 2023
|
PRIMARY | |||
|
869769-98-2
Created by
admin on Sat Dec 16 04:58:52 GMT 2023 , Edited by admin on Sat Dec 16 04:58:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |